Yesterday, Hardison & Cochran filed the first of many cases against DePuy Orthopaedics, Inc., and its parent company, Johnson & Johnson. In August 2010, Depuy Orthopaedics recalled two of their hip replacement systems. The recall has been issued for approximately 93,000 defective implants after it was found that the device was failing at a rate of 12%-15%. Due to this failure, many patients were requiring additional surgeries to revise the original hip replacement. The two implants being recalled are the ASR™ Acetabular Cup System and DePuy ASR™ Hip Resurfacing System. The DePuy ASR™ Acetabular Cup System is a metal-on-metal hip component used during a hip replacement surgery in the United States and worldwide. It was introduced in 2004. The ASR™ hip resurfacing system, which is used in a popular alternative to tradition hip replacement, has not been approved in the United States but has been used abroad.
Managing Partner of Hardison & Cochran, Ben Cochran, spoke briefly today about the filings. “This is a dangerous product that should have never been marketed. It is subject to a high failure rate, and is likely to cause metal toxicity,” said Cochran. “In addition to this case being filed, we’re investigating many cases where a person’s well being suffered tremendously due to this product’s failure,” he added.
For a full look at the DePuy Hip Replacement Recall news covered on our blog, please click here